Evivo in the NICU

Resolve gut dysbiosis and improve clinical outcomes in your NICU patients

Growing body of evidence demonstrates a clear functional advantage to feeding the targeted bacterial strain B. infantis EVC001 to human milk-fed NICU infants

READ PEER-REVIEWED RESEARCH

Adminster Evivo with MCT Oil, once daily, to your NICU patients to:

Resolve gut dysbiosis
Reduce enteric inflamation
Reduce antibiotic resistance
Create a protective environment for the preterm infant gut
Improve clinical outcomes
Improves utilization of human milk oligosaccharides (HMOs) from breast milk

REQUEST A MEETING

Evivo for Pediatricians

Safeguard your infant patient’s short- and long-term health

The gut microbiome in more than 90% of babies born in the US today is dominated by potentially pathogenic bacteria, impacting their daily lives and lifelong health. Only Evivo is clinically proven to change the biochemistry of the infant gut by replacing potentially pathogenic bacteria with beneficial bacteria.

REQUEST MORE INFORMATION